List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 90 studies with search of: Australia, Tasmania
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
2 Recruiting Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate
3 Terminated Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
4 Completed Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
Condition: Heart Failure, Congestive
Intervention: Drug: Levosimendan
5 Recruiting Radiation Doses and Fractionation Schedules in Non-Low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
Condition: Carcinoma, Ductal, Breast
Interventions: Radiation: Whole breast radiation therapy alone - Standard schedule;   Radiation: Whole breast radiation therapy alone - Shorter schedule;   Radiation: Whole breast RT plus tumour bed boost - Standard schedule;   Radiation: Whole breast RT plus tumour bed boost - Shorter schedule
6 Active, not recruiting Chemotherapy and Radiotherapy for Osteolymphoma
Condition: Osteolymphoma
Interventions: Drug: Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone.;   Procedure: Radiotherapy
7 Recruiting Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia
Condition: Pneumonia
Intervention: Drug: Tifacogin
8 Recruiting Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate;   Drug: triptorelin;   Procedure: oophorectomy;   Radiation: radiation therapy
9 Recruiting Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Placebo
10 Recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
11 Terminated Open-Label Trial of LEUKINE® in Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Sargramostim (Leukine, BAY86-5326)
12 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
13 Recruiting Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: cyclophosphamide;   Drug: goserelin
14 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
15 Active, not recruiting The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine;   Drug: Humalog Low Mix
16 Recruiting E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
Condition: Metastatic Breast Cancer
Interventions: Drug: E7389;   Drug: Capecitabine
17 Active, not recruiting Phase 3 Trial of CP-675,206 Versus Either Dacarbazine or Temozolomide in Patients Without Prior Therapy
Condition: Melanoma
Interventions: Drug: dacarbazine or temozolomide (choice);   Drug: CP-675,206
18 Recruiting Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
19 Active, not recruiting Study to Assess the Safety of CDP870 for up to 84 Months Following Reintroduction of Treatment
Condition: Crohn's Disease
Intervention: Biological: CDP870
20 Active, not recruiting Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: methotrexate;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: adjuvant therapy;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services